These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6381336)
1. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study. Nardini M; De Stefano R; Iannuccelli M; Borghesi R; Battistini N Int J Clin Pharmacol Res; 1983; 3(4):239-50. PubMed ID: 6381336 [TBL] [Abstract][Full Text] [Related]
2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. Alpert JE; Franznick DA; Hollander SB; Fava M J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of essential headache in developmental age with L-5-HTP (cross over double-blind study versus placebo)]. Longo G; Rudoi I; Iannuccelli M; Strinati R; Panizon F Pediatr Med Chir; 1984; 6(2):241-5. PubMed ID: 6397729 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195 [TBL] [Abstract][Full Text] [Related]
6. Valproate as an antidepressant in major depressive disorder. Davis LL; Kabel D; Patel D; Choate AD; Foslien-Nash C; Gurguis GN; Kramer GL; Petty F Psychopharmacol Bull; 1996; 32(4):647-52. PubMed ID: 8993086 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825 [TBL] [Abstract][Full Text] [Related]
8. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Isaac MT; Isaac MB; Gallo F; Tournoux A Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence]. Daléry J; Aubin V Encephale; 2001; 27(1):71-81. PubMed ID: 11294041 [TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
11. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients. Rousseau JJ Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702 [TBL] [Abstract][Full Text] [Related]
12. [Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression]. Möller HJ; Kissling W; Herberger B; Kuss HJ Pharmacopsychiatry; 1984 Jan; 17(1):29-33. PubMed ID: 6369348 [TBL] [Abstract][Full Text] [Related]
13. Double blind test with mianserin versus chlorimipramine. Rapisarda V; Bongiorno G Adv Biochem Psychopharmacol; 1982; 32():141-9. PubMed ID: 6283807 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
17. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886 [TBL] [Abstract][Full Text] [Related]
18. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode. Jangid P; Malik P; Singh P; Sharma M; Gulia AK Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of Hydiphen in the treatment of endogenous depression]. Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]